tiprankstipranks
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (HK:2190)
:2190
Hong Kong Market
2190
Zylox-Tonbridge Medical Technology Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2190 full AI Analyst Report?

Zylox-Tonbridge Medical Technology Co., Ltd. Class H (2190) Ratios

2 Followers

Zylox-Tonbridge Medical Technology Co., Ltd. Class H Ratios

HK:2190's free cash flow for Q4 2025 was ¥0.73. For the 2025 fiscal year, HK:2190's free cash flow was decreased by ¥ and operating cash flow was ¥0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.98 5.98 4.58 5.40 13.56
Quick Ratio
 5.41 5.41 3.96 4.83 12.78
Cash Ratio
 1.78 1.78 1.25 3.42 7.93
Solvency Ratio
 0.80 0.81 0.37 -0.13 -0.55
Operating Cash Flow Ratio
 0.71 1.16 0.52 0.31 -0.60
Short-Term Operating Cash Flow Coverage
 3.70 6.05 2.00 1.97 0.00
Net Current Asset Value
¥ 1.60B¥ 1.60B¥ 1.18B¥ 1.39B¥ 1.90B
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.03 0.02 <0.01
Debt-to-Equity Ratio
 0.02 0.02 0.03 0.02 <0.01
Debt-to-Capital Ratio
 0.02 0.02 0.03 0.02 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.11 1.11 1.11 1.11 1.05
Debt Service Coverage Ratio
 3.84 3.78 0.73 -0.81 -129.39
Interest Coverage Ratio
 0.00 197.32 28.01 -125.12 -288.64
Debt to Market Cap
 0.01 <0.01 0.02 0.01 0.00
Interest Debt Per Share
 0.20 0.20 0.29 0.17 0.04
Net Debt to EBITDA
 -2.23 -2.23 -5.01 24.77 13.76
Profitability Margins
Gross Profit Margin
72.14%72.14%71.55%72.95%75.63%
EBIT Margin
18.77%18.80%4.62%-14.68%-33.77%
EBITDA Margin
21.93%21.93%8.34%-7.88%-25.91%
Operating Profit Margin
18.59%18.59%7.78%-29.66%-62.38%
Pretax Profit Margin
21.81%21.81%12.81%-14.92%-33.99%
Net Profit Margin
22.91%23.11%12.81%-14.92%-33.99%
Continuous Operations Profit Margin
22.91%23.11%12.81%-14.92%-33.99%
Net Income Per EBT
105.07%105.97%100.00%100.00%100.00%
EBT Per EBIT
117.28%117.28%164.58%50.30%54.49%
Return on Assets (ROA)
6.78%6.84%2.90%-2.33%-3.49%
Return on Equity (ROE)
7.59%7.56%3.23%-2.58%-3.67%
Return on Capital Employed (ROCE)
6.05%6.05%1.95%-5.12%-6.72%
Return on Invested Capital (ROIC)
5.94%5.94%1.90%-5.03%-6.70%
Return on Tangible Assets
6.86%6.91%2.93%-2.34%-3.54%
Earnings Yield
4.16%3.64%2.80%-2.12%-3.03%
Efficiency Ratios
Receivables Turnover
 47.55 47.55 508.43 446.49 329.48
Payables Turnover
 4.73 4.73 3.21 3.36 4.46
Inventory Turnover
 1.58 1.58 1.08 0.78 0.68
Fixed Asset Turnover
 1.49 1.49 1.18 0.91 1.07
Asset Turnover
 0.30 0.30 0.23 0.16 0.10
Working Capital Turnover Ratio
 0.67 0.75 0.60 0.32 0.14
Cash Conversion Cycle
 160.89 160.89 223.91 361.90 453.83
Days of Sales Outstanding
 7.68 7.68 0.72 0.82 1.11
Days of Inventory Outstanding
 230.30 230.30 336.95 469.59 534.56
Days of Payables Outstanding
 77.09 77.09 113.75 108.51 81.83
Operating Cycle
 237.98 237.98 337.67 470.41 535.66
Cash Flow Ratios
Operating Cash Flow Per Share
 0.72 1.17 0.54 0.30 -0.28
Free Cash Flow Per Share
 0.54 0.83 -0.05 -0.28 -0.72
CapEx Per Share
 0.19 0.33 0.59 0.58 0.44
Free Cash Flow to Operating Cash Flow
 0.74 0.71 -0.10 -0.94 2.59
Dividend Paid and CapEx Coverage Ratio
 3.82 2.69 0.91 0.52 -0.63
Capital Expenditure Coverage Ratio
 3.89 3.48 0.91 0.52 -0.63
Operating Cash Flow Coverage Ratio
 3.62 5.92 1.91 1.76 -6.52
Operating Cash Flow to Sales Ratio
 0.22 0.36 0.22 0.19 -0.27
Free Cash Flow Yield
3.02%4.00%-0.48%-2.50%-6.32%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 24.05 27.47 35.68 -47.06 -32.99
Price-to-Sales (P/S) Ratio
 5.36 6.35 4.57 7.02 11.21
Price-to-Book (P/B) Ratio
 1.80 2.08 1.15 1.22 1.21
Price-to-Free Cash Flow (P/FCF) Ratio
 33.06 24.98 -207.21 -40.07 -15.83
Price-to-Operating Cash Flow Ratio
 25.27 17.81 20.55 37.64 -41.02
Price-to-Earnings Growth (PEG) Ratio
 0.17 0.19 -0.16 1.60 0.66
Price-to-Fair Value
 1.80 2.08 1.15 1.22 1.21
Enterprise Value Multiple
 22.20 26.72 49.77 -64.29 -29.51
Enterprise Value
 5.15B 6.20B 3.25B 2.67B 2.55B
EV to EBITDA
 22.20 26.72 49.77 -64.29 -29.51
EV to Sales
 4.87 5.86 4.15 5.07 7.65
EV to Free Cash Flow
 30.05 23.06 -188.26 -28.92 -10.80
EV to Operating Cash Flow
 22.32 16.44 18.67 27.17 -27.97
Tangible Book Value Per Share
 9.98 9.86 9.50 9.24 9.23
Shareholders’ Equity Per Share
 10.11 9.99 9.59 9.27 9.37
Tax and Other Ratios
Effective Tax Rate
 -0.03 -0.03 0.00 0.00 -0.06
Revenue Per Share
 3.31 3.27 2.42 1.61 1.01
Net Income Per Share
 0.76 0.76 0.31 -0.24 -0.34
Tax Burden
 1.05 1.06 1.00 1.00 1.00
Interest Burden
 1.16 1.16 2.77 1.02 1.01
Research & Development to Revenue
 0.23 0.23 0.30 0.49 0.70
SG&A to Revenue
 0.30 0.30 0.34 0.22 0.33
Stock-Based Compensation to Revenue
 <0.01 0.00 0.03 0.16 0.26
Income Quality
 0.95 1.58 1.74 -1.25 0.80
Currency in CNY